BENZYL-[(2R)-N-BENZYLOXYCARBONYL-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-TRIESTER
Compound with spectra: 1 NMR
![BENZYL-[(2R)-N-BENZYLOXYCARBONYL-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-TRIESTER](/api/compound/3V5UYWLXxzY.png?ph=true&h=300&w=458 "BENZYL-[(2R)-N-BENZYLOXYCARBONYL-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-TRIESTER")
| SpectraBase Compound ID | 3V5UYWLXxzY |
|---|---|
| InChI | InChI=1S/C40H47N5O12/c1-54-38(51)30(18-19-33(46)42-24-36(49)56-25-28-14-8-4-9-15-28)43-34(47)20-21-41-37(50)31(22-27-12-6-3-7-13-27)44-35(48)23-32(39(52)55-2)45-40(53)57-26-29-16-10-5-11-17-29/h3-17,30-32H,18-26H2,1-2H3,(H,41,50)(H,42,46)(H,43,47)(H,44,48)(H,45,53)/t30-,31-,32+/m0/s1 |
| InChIKey | GPMLYQNCDZRYRF-OWHBQTKESA-N |
| Mol Weight | 789.8 g/mol |
| Molecular Formula | C40H47N5O12 |
| Exact Mass | 789.322122 g/mol |
| Enantiomer InChIKey | GPMLYQNCDZRYRF-IWWXRALLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINE-DIESTER;ROTAMER-#2;COMPOUN
[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINE-DIESTER;ROTAMER-#1;COMPOU
CYCLO-[BETA-ALA-(R)-GLU-ALPHA-OME-GAMMA-SAR-(R)-ASP-ALPHA-OME-BETA-(S)-PHE];ROTAMER-#1
CYCLO-[BETA-ALA-(R)-GLU-ALPHA-OME-GAMMA-SAR-(R)-ASP-ALPHA-OME-BETA-(S)-PHE];ROTAMER-#2
di-tert-butyl 2-(2-(2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-4-methylpentanamido)pentanedioate
#25;O-ETHYL-[N-(BENZYLOXYCARBONYL)-N-[4-[N'-(BENZYLOXYCARBONYL)-AMINO]-BUTYL]-4-AMINOBUTYL]-[[(ALPHA-O-BENZYL-Z-GAMMA-GLUTAMYLALANINYL)-AMINO]-METHYL]-PHOSPHIN
TERT.-BUTOXYCARBONYL-GAMMA-BENZYL-L-GLUTAMYLGLYCYL-L-GLUTAMINYL-N-(EPSILON)-BENZOYLOXYCARBONYL-L-LYSINE-BENZYLESTER
N-METHYL-(R)-2-[(R)-2-(HYDROXYAMINO)-1-(2-HYDROXYACETYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
{2-Phenyl-1-[(pyridin-4-ylmethyl)carbamoyl]ethyl}carbamic acid 4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)benzyl ester
benzyl 2-(butylamino)-1-(1H-indol-3-ylmethyl)-2-oxoethylcarbamate
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |